Our latest paper is out! Fantastic collaboration with Olivier Devuyst's lab at the University of Zurich. Alpelisib rescues actin phenotypes and endocytic uptake in OCRL deficient cells and improves proteinuria in the mouse model of Lowe syndrome/Dent disease 2. Featured in [Business Weekly](https://www.businessweekly.co.uk/news/academia-research/cancer-drug-can-rebalance-kidney-function-devastating-genetic-disease), [Cambridge Network](https://www.cambridgenetwork.co.uk/news/cancer-drug-can-rebalance-kidney-function-devastating-genetic-disease) and [EurekAlert](https://www.eurekalert.org/pub_releases/2020-09/wtcr-cdc090320.php)
